Phase 2
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Adenocarcinoma, Stomach Cancer, Cancer of Esophagogastric Junction
Both
Adenocarcinoma, Stomach Cancer, Cancer of Esophagogastric Junction
Trial Information
Inclusion Criteria
Inclusion criteria:
- Histological prove of adenocarcinoma of the stomach.
Exclusion criteria:
- Recurrent gastric carcinoma
- No informed consent
- Previous malignancy (exception: thyroid, bladder in situ, Cervix in situ)
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic
Outcome Measure:
Diagnostic Accuracy of PET-CT
Outcome Time Frame:
preoperative
Safety Issue:
No
Principal Investigator
01 Studienregister MasterAdmins
Investigator Role:
Study Director
Investigator Affiliation:
UniversitaetsSpital Zuerich
Authority:
Switzerland: Ethikkommission
Study ID:
VIS-UGI-1
NCT ID:
NCT00800969
Start Date:
October 2008
Completion Date:
Related Keywords:
- Adenocarcinoma
- Stomach Cancer
- Cancer of Esophagogastric Junction
- Adenocarcinoma of the stomach and esophagogastric junction
- Adenocarcinoma
- Adenocarcinoma, Mucinous
- Stomach Neoplasms
Name | Location |
|---|
